1. Home
  2. NKTX vs PAYS Comparison

NKTX vs PAYS Comparison

Compare NKTX & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTX
  • PAYS
  • Stock Information
  • Founded
  • NKTX 2015
  • PAYS 2001
  • Country
  • NKTX United States
  • PAYS United States
  • Employees
  • NKTX N/A
  • PAYS N/A
  • Industry
  • NKTX Biotechnology: Pharmaceutical Preparations
  • PAYS Business Services
  • Sector
  • NKTX Health Care
  • PAYS Consumer Discretionary
  • Exchange
  • NKTX Nasdaq
  • PAYS Nasdaq
  • Market Cap
  • NKTX 123.5M
  • PAYS 125.2M
  • IPO Year
  • NKTX 2020
  • PAYS 1998
  • Fundamental
  • Price
  • NKTX $1.80
  • PAYS $7.88
  • Analyst Decision
  • NKTX Strong Buy
  • PAYS Strong Buy
  • Analyst Count
  • NKTX 6
  • PAYS 4
  • Target Price
  • NKTX $14.40
  • PAYS $7.06
  • AVG Volume (30 Days)
  • NKTX 434.5K
  • PAYS 1.1M
  • Earning Date
  • NKTX 08-12-2025
  • PAYS 08-05-2025
  • Dividend Yield
  • NKTX N/A
  • PAYS N/A
  • EPS Growth
  • NKTX N/A
  • PAYS N/A
  • EPS
  • NKTX N/A
  • PAYS 0.11
  • Revenue
  • NKTX N/A
  • PAYS $63,792,627.00
  • Revenue This Year
  • NKTX N/A
  • PAYS $30.03
  • Revenue Next Year
  • NKTX N/A
  • PAYS $20.14
  • P/E Ratio
  • NKTX N/A
  • PAYS $71.65
  • Revenue Growth
  • NKTX N/A
  • PAYS 26.77
  • 52 Week Low
  • NKTX $1.31
  • PAYS $1.80
  • 52 Week High
  • NKTX $8.23
  • PAYS $8.57
  • Technical
  • Relative Strength Index (RSI)
  • NKTX 51.45
  • PAYS 85.08
  • Support Level
  • NKTX $1.68
  • PAYS $4.72
  • Resistance Level
  • NKTX $1.84
  • PAYS $8.57
  • Average True Range (ATR)
  • NKTX 0.08
  • PAYS 0.50
  • MACD
  • NKTX 0.01
  • PAYS 0.12
  • Stochastic Oscillator
  • NKTX 80.95
  • PAYS 95.89

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About PAYS Paysign Inc.

PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.

Share on Social Networks: